Cargando…
Decreased abundance of Akkermansia after adrenocorticotropic hormone therapy in patients with West syndrome
BACKGROUND: Infants suffer from a severe epileptic encephalopathy known as West syndrome (WS). Treatment with adrenocorticotropic hormone (ACTH) indicates the involvement of the gut-brain axis in WS. Several pieces of evidence show the communication of the gut microbiota (GM) with the brain via the...
Autores principales: | Xu, Lu, Chen, Dandan, Zhao, Congying, Jiang, Lihua, Mao, Shanshan, Song, Chao, Gao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063292/ https://www.ncbi.nlm.nih.gov/pubmed/33892634 http://dx.doi.org/10.1186/s12866-021-02189-z |
Ejemplares similares
-
Retrospective Echocardiographic Analysis of West Syndrome During Adrenocorticotropic Hormone Therapy
por: Ikuta, Yoji, et al.
Publicado: (2022) -
Adrenocorticotropic Hormone Induced Status Dystonicus in a Child with West Syndrome
por: Singh, Jasmine, et al.
Publicado: (2022) -
Histopathologic Differences Between Adrenocorticotropic Hormone–Dependent and Adrenocorticotropic Hormone–Independent Adrenal Hyperplasia Causing Cushing Syndrome
por: Pishdad, Reza, et al.
Publicado: (2022) -
Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series
por: Baba, Shimpei, et al.
Publicado: (2021) -
Cost-effectiveness of adrenocorticotropic hormone injection and oral prednisolone in patients with West syndrome: A comparative analysis
por: Sharawat, Indar Kumar, et al.
Publicado: (2023)